Flynn Peter D

See remarks at FATE THERAPEUTICS INC · on record since Jan 10, 2014
EVP, Head of Global Dev at Orexigen Therapeutics, Inc. · on record since Oct 17, 2017

Insider trading activity of Flynn Peter D

Transactions on record: 40; since Jan 10, 2014

Open-market buys: 0

Open-market sells: 10; $224.4K

Companies traded: 2; last filing Oct 17, 2017

Figures computed from official regulatory filings — .

Companies where Flynn Peter D has traded

Orexigen Therapeutics, Inc.7 tx · Oct 17, 2017
FATE THERAPEUTICS INC33 tx · $261.4K · Jan 7, 2015

Track record of Flynn Peter D

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Flynn Peter D

Co-insiders of Flynn Peter D

ABBOT STEWARTFATE THERAPEUTICS INC
ABERNETHY MATTFATE THERAPEUTICS INC
ACE HEATHER SOrexigen Therapeutics, Inc.
Adawi KamalFATE THERAPEUTICS INC
Agarwal ShefaliFATE THERAPEUTICS INC
ARCH VENTURE FUND VI LPFATE THERAPEUTICS INC
ARCH VENTURE PARTNERS VI LLCFATE THERAPEUTICS INC
ARCH VENTURE PARTNERS VI LPFATE THERAPEUTICS INC
Arkin MosheOrexigen Therapeutics, Inc.
BAUM CAROL AOrexigen Therapeutics, Inc.
Baupost Group GP, L.L.C.Orexigen Therapeutics, Inc.
BAUPOST GROUP LLC/MAOrexigen Therapeutics, Inc.
BA Venture Partners VII, LLCOrexigen Therapeutics, Inc.
BAVP VII LPOrexigen Therapeutics, Inc.
BLAIR JAMES COrexigen Therapeutics, Inc.
BOCK LOUIS COrexigen Therapeutics, Inc.
Booth Mark DOrexigen Therapeutics, Inc.
BREEN DORONOrexigen Therapeutics, Inc.
Bressi Jerome CharlesFATE THERAPEUTICS INC
BYBEE CLINTONFATE THERAPEUTICS INC
BYMASTER FRANKLIN POrexigen Therapeutics, Inc.
Cannell Thomas ROrexigen Therapeutics, Inc.
Chu Yu-WayeFATE THERAPEUTICS INC
COOPER GRAHAM KOrexigen Therapeutics, Inc.
Coughlin Timothy PFATE THERAPEUTICS INC

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Orexigen Therapeutics, Inc.Listing unverified	Oct 17, 2017	AwardD (derivative)	69,600	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Orexigen Therapeutics, Inc.Listing unverified	Feb 7, 2017	AwardD (derivative)	43,500	—	n/a (No price was disclosed in the filing)	SEC
Orexigen Therapeutics, Inc.Listing unverified	Feb 7, 2017	AwardD (derivative)	87,000	—	n/a (No price was disclosed in the filing)	SEC
Orexigen Therapeutics, Inc.Listing unverified	Jul 14, 2016	AwardD (derivative)	15,750	—	n/a (No price was disclosed in the filing)	SEC
Orexigen Therapeutics, Inc.Listing unverified	Jul 14, 2016	AwardD (derivative)	78,750	—	n/a (No price was disclosed in the filing)	SEC
Orexigen Therapeutics, Inc.Listing unverified	Jul 14, 2016	AwardD (derivative)	26,250	—	n/a (No price was disclosed in the filing)	SEC
Orexigen Therapeutics, Inc.Listing unverified	Jul 14, 2016	AwardD (derivative)	131,250	—	n/a (No price was disclosed in the filing)	SEC
FATE THERAPEUTICS INCListing on record	Jan 7, 2015	AwardD (derivative)	70,000	—	n/a (No price was disclosed in the filing)	SEC
FATE THERAPEUTICS INCListing on record	Jan 7, 2015	Award	2,466	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
FATE THERAPEUTICS INCListing on record	Jun 12, 2014	ExerciseD (derivative)	-422	—	n/a (No price was disclosed in the filing)	SEC
FATE THERAPEUTICS INCListing on record	Jun 12, 2014	Sell	-1,017	7.00 USD	$7.1K	SEC
FATE THERAPEUTICS INCListing on record	Jun 12, 2014	ExerciseD (derivative)	-1,100	—	n/a (No price was disclosed in the filing)	SEC
FATE THERAPEUTICS INCListing on record	Jun 12, 2014	Exercise	3,949	1.63 USD	$6.4K	SEC
FATE THERAPEUTICS INCListing on record	Jun 12, 2014	ExerciseD (derivative)	-1,017	—	n/a (No price was disclosed in the filing)	SEC
FATE THERAPEUTICS INCListing on record	Jun 12, 2014	Exercise	1,017	1.63 USD	$1.7K	SEC
FATE THERAPEUTICS INCListing on record	Jun 12, 2014	Exercise	422	1.37 USD	$578.1	SEC
FATE THERAPEUTICS INCListing on record	Jun 12, 2014	Sell	-5,471	7.00 USD	$38.3K	SEC
FATE THERAPEUTICS INCListing on record	Jun 12, 2014	ExerciseD (derivative)	-3,949	—	n/a (No price was disclosed in the filing)	SEC
FATE THERAPEUTICS INCListing on record	Jun 12, 2014	Exercise	1,100	1.63 USD	$1.8K	SEC
FATE THERAPEUTICS INCListing on record	Jun 11, 2014	ExerciseD (derivative)	-699	—	n/a (No price was disclosed in the filing)	SEC
FATE THERAPEUTICS INCListing on record	Jun 11, 2014	Sell	-1,350	7.00 USD	$9.5K	SEC
FATE THERAPEUTICS INCListing on record	Jun 11, 2014	Exercise	1,260	1.63 USD	$2.1K	SEC
FATE THERAPEUTICS INCListing on record	Jun 11, 2014	Sell	-1,955	7.00 USD	$13.7K	SEC
FATE THERAPEUTICS INCListing on record	Jun 11, 2014	Exercise	699	1.63 USD	$1.1K	SEC
FATE THERAPEUTICS INCListing on record	Jun 11, 2014	ExerciseD (derivative)	-1,260	—	n/a (No price was disclosed in the filing)	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Orexigen Therapeutics, Inc.Listing unverified	Oct 17, 2017	AwardD (derivative)	69,600	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Orexigen Therapeutics, Inc.Listing unverified	Feb 7, 2017	AwardD (derivative)	43,500	—	n/a (No price was disclosed in the filing)	SEC
Orexigen Therapeutics, Inc.Listing unverified	Feb 7, 2017	AwardD (derivative)	87,000	—	n/a (No price was disclosed in the filing)	SEC
Orexigen Therapeutics, Inc.Listing unverified	Jul 14, 2016	AwardD (derivative)	15,750	—	n/a (No price was disclosed in the filing)	SEC
Orexigen Therapeutics, Inc.Listing unverified	Jul 14, 2016	AwardD (derivative)	78,750	—	n/a (No price was disclosed in the filing)	SEC
Orexigen Therapeutics, Inc.Listing unverified	Jul 14, 2016	AwardD (derivative)	26,250	—	n/a (No price was disclosed in the filing)	SEC
Orexigen Therapeutics, Inc.Listing unverified	Jul 14, 2016	AwardD (derivative)	131,250	—	n/a (No price was disclosed in the filing)	SEC
FATE THERAPEUTICS INCListing on record	Jan 7, 2015	AwardD (derivative)	70,000	—	n/a (No price was disclosed in the filing)	SEC
FATE THERAPEUTICS INCListing on record	Jan 7, 2015	Award	2,466	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
FATE THERAPEUTICS INCListing on record	Jun 12, 2014	ExerciseD (derivative)	-422	—	n/a (No price was disclosed in the filing)	SEC
FATE THERAPEUTICS INCListing on record	Jun 12, 2014	Sell	-1,017	7.00 USD	$7.1K	SEC
FATE THERAPEUTICS INCListing on record	Jun 12, 2014	ExerciseD (derivative)	-1,100	—	n/a (No price was disclosed in the filing)	SEC
FATE THERAPEUTICS INCListing on record	Jun 12, 2014	Exercise	3,949	1.63 USD	$6.4K	SEC
FATE THERAPEUTICS INCListing on record	Jun 12, 2014	ExerciseD (derivative)	-1,017	—	n/a (No price was disclosed in the filing)	SEC
FATE THERAPEUTICS INCListing on record	Jun 12, 2014	Exercise	1,017	1.63 USD	$1.7K	SEC
FATE THERAPEUTICS INCListing on record	Jun 12, 2014	Exercise	422	1.37 USD	$578.1	SEC
FATE THERAPEUTICS INCListing on record	Jun 12, 2014	Sell	-5,471	7.00 USD	$38.3K	SEC
FATE THERAPEUTICS INCListing on record	Jun 12, 2014	ExerciseD (derivative)	-3,949	—	n/a (No price was disclosed in the filing)	SEC
FATE THERAPEUTICS INCListing on record	Jun 12, 2014	Exercise	1,100	1.63 USD	$1.8K	SEC
FATE THERAPEUTICS INCListing on record	Jun 11, 2014	ExerciseD (derivative)	-699	—	n/a (No price was disclosed in the filing)	SEC
FATE THERAPEUTICS INCListing on record	Jun 11, 2014	Sell	-1,350	7.00 USD	$9.5K	SEC
FATE THERAPEUTICS INCListing on record	Jun 11, 2014	Exercise	1,260	1.63 USD	$2.1K	SEC
FATE THERAPEUTICS INCListing on record	Jun 11, 2014	Sell	-1,955	7.00 USD	$13.7K	SEC
FATE THERAPEUTICS INCListing on record	Jun 11, 2014	Exercise	699	1.63 USD	$1.1K	SEC
FATE THERAPEUTICS INCListing on record	Jun 11, 2014	ExerciseD (derivative)	-1,260	—	n/a (No price was disclosed in the filing)	SEC